# Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)

> **NCT03140280** · PHASE2 · COMPLETED · sponsor: **Ehab L Atallah** · enrollment: 23 (actual)

## Conditions studied

- Myelodysplastic Syndromes

## Interventions

- **DRUG:** Freeze-Dried Black Raspberry Powder

## Key facts

- **NCT ID:** NCT03140280
- **Lead sponsor:** Ehab L Atallah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-06-05
- **Primary completion:** 2019-06-01
- **Final completion:** 2021-05-28
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2022-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140280

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140280, "Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03140280. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*